Skip to main content
OpenTrials

Clinical trial condition

Autoimmune Diseases

Explore clinical trials studying Autoimmune Diseases. Study availability and eligibility vary by location and protocol.

10,989 public trials 1,669 recruiting studies
Refine in advanced search Browse all conditions

Autoimmune Diseases trial results

Recruiting

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

NCT06994845

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Childrens Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Prim Childrens Hosp Inv Pharm Salt Lake City, Utah, United States
  • Novartis Investigative Site Brisbane, Queensland, Australia
View all 20 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

NCT06782490

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +13 more
Locations
  • Alabama Neurology Associates Birmingham, Alabama, United States
  • Perseverance Research Center,LLC Scottsdale, Arizona, United States
  • Local Institution - 0017 Aurora, Colorado, United States
  • Aqualane Clinical Research Naples, Florida, United States
View all 55 locations
View Trial Details
Recruiting

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

NCT07421167

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • DH Cancer Research Center LLC Margate, Florida, United States
  • Hope And Healing Care Hinsdale, Illinois, United States
View all 13 locations
View Trial Details
Recruiting

Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

NCT06751238

Conditions
Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +7 more
Locations
  • Ann and Robert H Lurie Childs Hosp Chicago, Illinois, United States
  • Levine Childrens Hospital Charlotte, North Carolina, United States
  • Cincinnati Childrens Hospital Cincinnati, Ohio, United States
  • Univ Hosp Cleveland Medical Center Cleveland, Ohio, United States
View Trial Details
Recruiting

SG301-SC Injection Safety Study in Subjects With Primary ITP Patients

NCT07710248

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Pingdingshan First People's Hospital Pingdingshan, Henan, China
  • Jining No.1 People's Hospital Jining, Shandong, China
  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View all 22 locations
View Trial Details
Recruiting

Cannabis (THC vs. CBD) in Multiple Sclerosis

NCT06261489

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chemically-Induced Disorders, +8 more
Locations
  • University of Calgary Calgary, Alberta, Canada
  • University of Calgary Foothills Medical Center Calgary, Alberta, Canada
View Trial Details
Recruiting

A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

NCT06875960

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE), +4 more
Locations
  • Local Institution - 0001 Farmington, Connecticut, United States
  • New York University School Of Medicine New York, United States
  • Oklahoma Medical Research Foundation Oklahoma City, Oklahoma, United States
  • Local Institution - 0003 Jackson, Tennessee, United States
View Trial Details
Recruiting

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

NCT07216391

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • University of Florida Gainesville, Florida, United States
  • Barbara Davis Center Aurora, Colorado, United States
  • Yale University New Haven, Connecticut, United States
  • Columbia University New York, United States
View Trial Details

Related conditions